GE HealthCare Technologies Inc. with ticker code (GEHC) now have 8 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The target price High/Low ranges between 99 and 78 calculating the average target price we see $89.63. Now with the previous closing price of $71.59 and the analysts are correct then we can expect a percentage increase in value of 25.2%. It’s also worth noting that there is a 50 day moving average of $78.69 and the 200 moving average now moves to $74.92. The market capitalization for the company is 32.66B. The stock price is currently at: 71.8 USD
The potential market cap would be $40,886,718,465 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 20.57, revenue per share of 41.86 and a 5.77% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
